NCT00687687: Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma |
|
|
| Completed | 2 | 22 | US | paclitaxel, carboplatin, BSI-201 (Iniparib), SAR204550 | Sanofi, Gynecologic Oncology Group | Uterine Carcinosarcoma | 03/10 | 12/11 | | |